Great strides made but still further to go
Crossref DOI link: https://doi.org/10.1038/nrendo.2015.143
Published Online: 2015-08-25
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Reid, Ian R.
Text and Data Mining valid from 2015-08-25
Article History
First Online: 25 August 2015
Competing interests
: I.R.R. has received research funding from Amgen, Merck and Novartis, and has received honoraria from Amgen, Lilly, Merck, Novartis and Sanofi.